To direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdose, and for other purposes.

H.R. 2351 would direct the Coast Guard to update its policies on treating drug overdoses by ensuring naloxone, a medication that reverses opioid overdoses, is available at all Coast Guard installations and in operational environments. The bill would also require the Coast Guard to participate in a Department of Defense tracking system to monitor the distribution of naloxone and the illegal use of controlled substances like fentanyl among Coast Guard members and personnel.

The legislation would clarify that federal laws prohibiting the manufacturing or distribution of controlled substances on vessels apply even when those substances are placed on board without the crew's knowledge or on unmanned vessels. This provision would strengthen the Coast Guard's ability to enforce drug trafficking laws in maritime settings.

If enacted, the bill would require the Coast Guard to brief Congress within two years on the use of opioids and overdose medication at its facilities, including information about the prevalence of illegal substance use among members and the effectiveness of the Coast Guard's substance abuse prevention and treatment processes.

The bill has passed the House and is currently in committee in the Senate, where it has been referred to the Committee on Commerce, Science, and Transportation. If approved by the Senate and signed into law, these changes would take effect at Coast Guard facilities nationwide.